Indeed, compared to normal tissues, NMT2 expression was significantly decreased in multiple tumor types (9/11) and metastatic tissues, including breast, lung, colon, and ovarian cancers (Additional file 1: Figs. S3, S4), whereas NMT1 expression was significantly increased in multiple tumor types (8/11) (Additional file 1: Fig. S3), and metastases (Additional file 1: Fig. S4). Here, NMT2 is linked to ovarian cancer.